MDT

87.95

+0.96%↑

A

117.5

+2.09%↑

VEEV

158.5

+4.65%↑

HQY

79.86

+2.23%↑

TLRY

6.73

+2.28%↑

MDT

87.95

+0.96%↑

A

117.5

+2.09%↑

VEEV

158.5

+4.65%↑

HQY

79.86

+2.23%↑

TLRY

6.73

+2.28%↑

MDT

87.95

+0.96%↑

A

117.5

+2.09%↑

VEEV

158.5

+4.65%↑

HQY

79.86

+2.23%↑

TLRY

6.73

+2.28%↑

MDT

87.95

+0.96%↑

A

117.5

+2.09%↑

VEEV

158.5

+4.65%↑

HQY

79.86

+2.23%↑

TLRY

6.73

+2.28%↑

MDT

87.95

+0.96%↑

A

117.5

+2.09%↑

VEEV

158.5

+4.65%↑

HQY

79.86

+2.23%↑

TLRY

6.73

+2.28%↑

Search

Evolent Health Inc

Geschlossen

BrancheGesundheitswesen

2.54 9.01

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.25

Max

2.55

Schlüsselkennzahlen

By Trading Economics

Einkommen

-408M

-429M

Verkäufe

-11M

469M

Gewinnspanne

-91.554

Angestellte

4,200

EBITDA

-374M

-360M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+120.6% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

7. Mai 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-63M

258M

Vorheriger Eröffnungskurs

-6.47

Vorheriger Schlusskurs

2.54

Nachrichtenstimmung

By Acuity

41%

59%

127 / 348 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

Evolent Health Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Apr. 2026, 23:25 UTC

Wichtige Nachrichtenereignisse

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy -- Update

13. Apr. 2026, 22:45 UTC

Wichtige Nachrichtenereignisse

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy

13. Apr. 2026, 18:03 UTC

Ergebnisse

Louis Vuitton Owner Logs Weak Sales as Middle East War Takes Toll -- 2nd Update

13. Apr. 2026, 23:58 UTC

Ergebnisse

Review & Preview: Earnings Time -- Barrons.com

13. Apr. 2026, 23:49 UTC

Market Talk

Nikkei May Rise After Overnight Gains on Wall Street -- Market Talk

13. Apr. 2026, 23:33 UTC

Market Talk
Wichtige Nachrichtenereignisse

Gold Edges Higher Amid Dollar Weakness -- Market Talk

13. Apr. 2026, 23:20 UTC

Market Talk

Uranium Stocks Seen Benefiting From Energy Security Concerns -- Market Talk

13. Apr. 2026, 23:01 UTC

Ergebnisse

Aura: Capex Guidance Revised From $111M and $130M to New Range of $262M and $314M >AURA33.SA.BR

13. Apr. 2026, 23:01 UTC

Ergebnisse

Aura Minerals: Announces Update to Capex Guidance Including Construction of the Era Dorada Project

13. Apr. 2026, 23:01 UTC

Ergebnisse

Aura: Will Update Cap Expenditure Guidance to Include the Project's Construction Phase >AURA33.SA.BR

13. Apr. 2026, 22:21 UTC

Akquisitionen, Fusionen, Übernahmen

Chevron Swaps Offshore Gas Stakes to Boost Venezuelan Heavy-Oil Footprint -- Update

13. Apr. 2026, 21:53 UTC

Ergebnisse

MarketWise, Inc.: Affirms FY 2026 Guidance, Including Div Target to Class A Hldrs of $1.80 per Shr

13. Apr. 2026, 21:53 UTC

Ergebnisse

MarketWise, Inc.: Paid Subscribers Were 381,000 at March 31 Compared to 374,000 at Dec 31, 2025, Active Free Subscribers Were 2.0M at March 31 >MKTW

13. Apr. 2026, 21:53 UTC

Ergebnisse

MarketWise, Inc.: 1Q Billings Increased Approximately 15% Yr-over-Yr to Approximately $81M

13. Apr. 2026, 21:53 UTC

Ergebnisse

MarketWise, Inc.: Preliminary Selected Unaudited 1Q Paid Subscribers Returning to Growth

13. Apr. 2026, 21:26 UTC

Wichtige Nachrichtenereignisse

U.S. Oil Blockade Is Set to Boost American Exports -- and Prices at the Pump -- WSJ

13. Apr. 2026, 21:23 UTC

Ergebnisse

Johnson & Johnson Earnings: Oncology Powers Growth, but Talc Lawsuits Persist -- Barrons.com

13. Apr. 2026, 21:16 UTC

Ergebnisse

Goldman Sachs Reports Record Quarter in Banking and Trading -- 4th Update

13. Apr. 2026, 20:50 UTC

Market Talk
Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

13. Apr. 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

13. Apr. 2026, 20:34 UTC

Ergebnisse

Victory Capital: 1Q Long-Term AUM Net Flows of -$457M >VCTR

13. Apr. 2026, 20:34 UTC

Ergebnisse

Victory Capital: March Avg Total AUM Was $315.3B, Avg Other Assets $3.2B, Avg Total Client Assets $318.5B >VCTR

13. Apr. 2026, 20:34 UTC

Ergebnisse

Victory Capital Holdings, Inc.: Total Assets Under Management of $309.8B, Other Assets $3.3B, Total Client Assets of $313.1B as of March 31 >VCTR

13. Apr. 2026, 19:59 UTC

Market Talk

Canada Consumers Sour Prior to Big Energy-Price Jump -- Market Talk

13. Apr. 2026, 19:50 UTC

Market Talk
Wichtige Nachrichtenereignisse

Oil Futures Pull Back From Highs on Hopes for Talks -- Market Talk

13. Apr. 2026, 19:27 UTC

Market Talk
Wichtige Nachrichtenereignisse

Correction to Precious Metals Market Talk on April 9

13. Apr. 2026, 19:14 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower on Mild Weather -- Market Talk

13. Apr. 2026, 18:59 UTC

Market Talk
Wichtige Nachrichtenereignisse

Fed's Goolsbee: Don't Be Surprised If Consumer Confidence Sours -- Market Talk

13. Apr. 2026, 18:59 UTC

Market Talk
Wichtige Nachrichtenereignisse

Fed's Goolsbee: Oil Shows People Expect Short Term Conflict in Iran -- Market Talk

13. Apr. 2026, 18:43 UTC

Market Talk

Precious Metals Lose Ground as U.S. Blockade in Hormuz Gets Underway -- Market Talk

Peer-Vergleich

Kursveränderung

Evolent Health Inc Prognose

Kursziel

By TipRanks

120.6% Vorteil

12-Monats-Prognose

Durchschnitt 5.14 USD  120.6%

Hoch 8 USD

Tief 3 USD

Basierend auf 14 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Evolent Health Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

14 ratings

12

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

10.33 / 10.95Unterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Very Strong Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

127 / 348 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat